Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/18/2003US20030176644 Compositions and methods for molecular biology
09/18/2003US20030176389 Administering to a subject suffering from gastrointestinal inflammation a formulation comprising an immunomodulatory nucleic acid to the subject, the immunomodulatory nucleic acid comprising the sequence 5'-CpG-3'
09/18/2003US20030176388 Fatty acid synthase mRNA binding protein
09/18/2003US20030176387 Regulation of human pyroglutamyl peptidase-like enzyme
09/18/2003US20030176386 Introducing a locus specific targeting fragment into the genome of a cell through homologous recombination by inhibiting endogenous mismatch repair of cell; introducing a locus specific targeting fragment into cell
09/18/2003US20030176385 For modulating the expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase
09/18/2003US20030176384 Antisense oligonucleotides for the inhibition of integrin alphav -subunit expression
09/18/2003US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression
09/18/2003US20030176380 Antisense modulation of helicase-moi expression
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176378 Vaccines and gene therapy compositions and methods of making and using the same
09/18/2003US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
09/18/2003US20030176376 Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof
09/18/2003US20030176374 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176371 For therapy of autoimmune disorders, cancer
09/18/2003US20030176355 Administering protein and biologically active substance; formulation acquires a non-liquid form under physiological conditions and biologically active substance is delivered from non-liquid to localized site
09/18/2003US20030176352 Peptides and related compounds having thrombopoietic activity
09/18/2003US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent
09/18/2003US20030176342 Novel potassium channel
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders
09/18/2003US20030176338 Novel serine-threonine kinase
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176330 55562 and 21617, novel human proteins and methods of use thereof
09/18/2003US20030176325 Modified peptide nucleic acid (PNA) molecules
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030176304 Protease variants and compositions
09/18/2003US20030175977 Bacteria reproduced in Deinococcus; endogenous plasmids
09/18/2003US20030175976 Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them
09/18/2003US20030175975 Using plasmid Dna; cyclic peptide
09/18/2003US20030175974 Human gene therapy
09/18/2003US20030175973 Targeted recombinant viral vectors
09/18/2003US20030175972 Cloning nucleic acids; virus vector
09/18/2003US20030175971 Differentiation and/or proliferation modulating agents and uses therefor
09/18/2003US20030175970 Digestion using restriction enzyme; gel purification
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175968 Endogenous cellular process; genetic engineering; using endonuclease
09/18/2003US20030175967 Animal cloning; vectors; genetic engineering
09/18/2003US20030175966 Cationic sugar derivatives for gene transfer
09/18/2003US20030175965 Insertion of vector into gene; genetic engineering, controlling gene expression
09/18/2003US20030175962 Gene encoding b protein
09/18/2003US20030175959 Genetically engineered skin cell types and toxicity assays
09/18/2003US20030175957 Pre-adipose cell lines
09/18/2003US20030175956 Feeder-free culture method for embryonic stem cell
09/18/2003US20030175953 Immortalized vascular adventital cell line
09/18/2003US20030175950 RNA interference mediated inhibition of HIV gene expression using short interfering RNA
09/18/2003US20030175940 Cell-wall degrading enzyme variants
09/18/2003US20030175937 Cathepsin O2 protease
09/18/2003US20030175936 Poly - gamma - glutamic acid decomposing enzyme gene and method for producing poly - gamma - glutamic acid
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175933 Mutants; detergents; active materials; oxidation resistance
09/18/2003US20030175932 Plant fungicide
09/18/2003US20030175931 DNA molecules coding for debranching enzymes derived from plants
09/18/2003US20030175929 Recombinant human creatine kinase heterodimer with solution-stability
09/18/2003US20030175928 Mitogen-activated protein kinase MEK6 and methods of use therefor
09/18/2003US20030175927 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003US20030175924 Human lysophosphatidic acid acyltransferase
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175919 ITI-D1 Kunitz domain mutants as hNE inhibitors
09/18/2003US20030175916 Nucleic acid which codes glycerol dehydratase
09/18/2003US20030175913 Anticancer agents; adding stimulants to plant cell culture
09/18/2003US20030175912 Method of producing L-serine by fermentation
09/18/2003US20030175910 Whole cell catalyst
09/18/2003US20030175909 Novel thermostable galactose isomerase and tagatose production thereby
09/18/2003US20030175908 Methods and means for manipulating nucleic acid
09/18/2003US20030175907 Method of constructing a synthetic polynucleotide
09/18/2003US20030175905 Anticholesterol agents; antilipemic agent; antiinflammatory agents; obesity
09/18/2003US20030175902 Methods for producing hyaluronan in a recombinant host cell
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175900 Compositions and methods for the treatment of tumor
09/18/2003US20030175898 Isolated nucleic acids; immune response disease
09/18/2003US20030175897 Human interferon, Zinf2
09/18/2003US20030175896 Use of CYP52A2A promoter to increase gene expression in yeast
09/18/2003US20030175895 Chemokine
09/18/2003US20030175894 Chemokine alpha-6
09/18/2003US20030175893 Metabolism mutant; nucleic acid cassette
09/18/2003US20030175892 Amino acid sequences encoding serine protease used in cleaning composition
09/18/2003US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use
09/18/2003US20030175887 Saturation mutagenesis in directed evolution
09/18/2003US20030175886 Used to prevent production of reactive oxygen radicals, oxidative stress
09/18/2003US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
09/18/2003US20030175883 DNA encoding a mammalian LPA receptor and uses thereof
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes